CureVac
Sandra Zellner is an experienced QA Expert in Research & Development and Quality by Design at CureVac, where responsibilities include resource planning for Corporate Quality, collaboration with the PMO team, and optimization of QTPP documents. Previous roles include Project Coordinator and Administrative Assistant in Corporate Program Management at CureVac, and a Business Process Analyst at Teva Pharmaceuticals, focusing on the implementation of a global database system and workflow optimization. Early career experience includes positions at Klinikverbund Südwest, Bosch, and Foster Apotheken, with a strong foundation in pharmaceutical manufacturing and quality control. Sandra holds educational qualifications in Pharmacy from The Julius Maximilians University of Würzburg and as a Pharmaceutical Technical Assistant from Naturwissenschaftlich-technische Akademie Isny.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.